AWS re:Invent 2019 – Daphne Koller of insitro Talks About Using AWS to Transform Drug Development
insitro is working to reinvent drug development, making it faster and less expensive. Leveraging machine learning on AWS, insitro is able to analyze massive amounts of high-content biological data in days rather than months, increasing the productivity of the drug development process. As a result, the company is helping usher in the era of digital biology—when insitro will be able to measure biological data with unprecedented precision and scale using machine learning to change human health.
To learn more, visit aws.amazon.com/machine-learning.